These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28292429)
1. Corrigendum to "SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth" [Biochem. Biophys. Res. Commun. 483 (2017) 880-884]. Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW Biochem Biophys Res Commun; 2017 Apr; 486(1):57. PubMed ID: 28292429 [No Abstract] [Full Text] [Related]
2. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth. Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696 [TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "The SIRT2 inhibitor AK-7 decreases cochlear cell apoptosis and attenuates noise-induced hearing loss" [Biochem. Biophys. Res. Commun. 509 (3) (2019) 641-646]. Liu Y; Ao L; Li Y; Zhao Y; Wen Y; Ding H Biochem Biophys Res Commun; 2019 Mar; 511(1):201. PubMed ID: 30773260 [No Abstract] [Full Text] [Related]
4. Corrigendum to "Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer" [Biochem. Biophys. Res. Commun. 529 (4) (3 September 2020) 1086-1093]. Fu J; Wang X; Yue Q Biochem Biophys Res Commun; 2021 Feb; 541():102. PubMed ID: 33478719 [No Abstract] [Full Text] [Related]
5. Corrigendum to "Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity" [Biochem. Biophys. Res. Commun. 496 (1) (2018 Jan 29) 76-82]. Yin K; Dang S; Cui L; Fan X; Xie R; Qu J; Shang M; Chen J Biochem Biophys Res Commun; 2018 Mar; 498(1):262. PubMed ID: 29506865 [No Abstract] [Full Text] [Related]
6. Corrigendum to "LncRNA LOC730101 promotes osteosarcoma cell survival under energy stress" [Biochem. Biophys. Res. Commun. 496 (1) (2018) 1-6]. Cheng G; Li B; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Liu W Biochem Biophys Res Commun; 2018 May; 499(2):396. PubMed ID: 29602573 [No Abstract] [Full Text] [Related]
7. Corrigendum to "Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer." [Biochem. Biophys. Res. Commun. 2014 oct 24, 453(3), 545-51]. Zheng L; Li X; Gu Y; Ma Y; Xi T Biochem Biophys Res Commun; 2020 Jan; 521(2):546-547. PubMed ID: 31672276 [No Abstract] [Full Text] [Related]
8. Corrigendum to "DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling" [Biochem. Biophys. Res. Commun. 450(1) (2014) 899-905]. Yang Y; Liu L; Cai J; Wu J; Guan H; Zhu X; Yuan J; Li M Biochem Biophys Res Commun; 2021 Sep; 568():195. PubMed ID: 34272055 [No Abstract] [Full Text] [Related]
9. Corrigendum to "TTK inhibitor promotes radiosensitivity of liver cancer cells through p21" [Biochem. Biophys. Res. Commun. 550(2021) 84-91]. Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X Biochem Biophys Res Commun; 2021 May; 555():214. PubMed ID: 33840464 [No Abstract] [Full Text] [Related]
10. Retraction notice to "The miR-599 promotes non-small cell lung cancer cell invasion via SATB2" [Biochem. Biophys. Res. Commun. 485/1 (2017) 35-40]. Tian W; Wang G; Liu Y; Huang Z; Zhang C; Ning K; Yu C; Shen Y; Wang M; Li Y; Wang Y; Zhang BC; Zhao Y Biochem Biophys Res Commun; 2019 Aug; 515(4):733. PubMed ID: 31239038 [No Abstract] [Full Text] [Related]
11. Corrigendum to "Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling" [Biochem. Biophys. Res. Commun. 524 (1) (2020) 1-7]. Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T Biochem Biophys Res Commun; 2021 Jan; 536():115. PubMed ID: 33390248 [No Abstract] [Full Text] [Related]
12. Retraction notice to "miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5" [Biochem. Biophys. Res. Commun. 458/3 (2015) 714-719]. Wang Y; Xu L; Jiang L Biochem Biophys Res Commun; 2019 Aug; 515(4):729. PubMed ID: 31239034 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Reactive oxygen species promotes cellular senescence in normal human epidermal keratinocytes through epigenetic regulation of p16(INK4a)" [Biochem. Biophys. Res. Commun. 452 (2014) 622-628]. Sasaki M; Kajiya H; Ozeki S; Okabe K; Ikebe T Biochem Biophys Res Commun; 2018 Oct; 505(2):634-635. PubMed ID: 30245135 [No Abstract] [Full Text] [Related]
14. Corrigendum to "A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells" [Biochem. Biophys. Res. Commun. 476 (2016) 42-48]. Zheng J; Choi KA; Kang PJ; Hyeon S; Kwon S; Moon JH; Hwang I; Kim YI; Kim YS; Yoon BS; Park G; Lee J; Hong S; You S Biochem Biophys Res Commun; 2017 Apr; 485(3):705. PubMed ID: 28237361 [No Abstract] [Full Text] [Related]
15. Retraction notice to "miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog" [Biochem. Biophys. Res. Commun. 480/3 (2016) 369-374]. Bi M; Chen W; Yu H; Wang J; Ding F; Tang DJ; Tang C Biochem Biophys Res Commun; 2019 Aug; 515(4):735. PubMed ID: 31239040 [No Abstract] [Full Text] [Related]
16. Corrigendum to "Angiogenic factor with G patch and FHA domains 1 (Aggf1) promotes hepatic steatosis in mice" [Biochem. Biophys. Res. Commun. 482 (1) 2017 134-140]. Shao J; Zeng S; Zhou B; Xu H; Bian Y; Xu Y Biochem Biophys Res Commun; 2020 Sep; 530(3):613-616. PubMed ID: 32684312 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Nanoelectroablation therapy for murine basal cell carcinoma" [Biochem. Biophys. Res. Commun. 424 (2012) 446-450]. Nuccitelli R; Tran K; Athos B; Kreis M; Nuccitelli P; Chang KS; Epstein EH; Tang JY Biochem Biophys Res Commun; 2016 Nov; 480(2):288. PubMed ID: 27793303 [No Abstract] [Full Text] [Related]
18. Corrigendum to "Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma" [Biochem. Biophys. Res. Commun. 692 (2024), 149344]. Ye X; Deng J; Dong C; Pan X; Lu Y Biochem Biophys Res Commun; 2024 Oct; 729():150352. PubMed ID: 38972138 [No Abstract] [Full Text] [Related]
19. Corrigendum to "Uncovering the underlying physical mechanism for cancer-immunity of MHC class I diversity". [Biochem. Biophys. Res. Commun. 504 (2018) 532-537. Li W; Wang J Biochem Biophys Res Commun; 2018 Dec; 507(1-4):526. PubMed ID: 30420283 [No Abstract] [Full Text] [Related]
20. Corrigendum to 'Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling' [Biochem. Biophys. Res. Commun. Volume 502, Issue 3, 20 July 2018, Pages 382-388]. Jiang C; He C; Wu Z; Li F; Xiao J Biochem Biophys Res Commun; 2018 Sep; 503(2):1178. PubMed ID: 29954602 [No Abstract] [Full Text] [Related] [Next] [New Search]